共 159 条
[1]
Burstein HJ(2014)Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update J Clin Oncol 33 2262-2269
[2]
Temin S(2008)Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer Br J Cancer 26 549-555
[3]
Anderson H(2010)Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients J Clin Oncol 18 337-346.e1
[4]
McCowan C(2016)Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL) Breast Cancer Res Treat 45 431-439
[5]
Shearer J(2015)Predictors of discontinuation of adjuvant hormone therapy in patients with breast cancer J Clin Oncol 7 378-387
[6]
Donnan PT(2012)Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review Breast Cancer Res Treat 167 615-633
[7]
Hershman DL(2017)Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review Patient Prefer Adherence 57 26-32
[8]
Kushi LH(2008)Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer J Clin Oncol Off J Am Soc Clin Oncol 138 185-191
[9]
Shao T(2005)Adherence beliefs among breast cancer patients taking tamoxifen Patient Educ Couns 125 3266-3274
[10]
Hershman DL(2009)Cancer treatment adherence among low-income women with breast or gynecologic cancer: a randomized controlled trial of patient navigation Cancer 114 163-173